Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

RedHill Biopharma Receives FDA Orphan Drug Designation for YELIVA® for the Treatment of Cholangiocar

b3cnewswireApril 05, 2017

Tag: Orphan Drug , cholangiocarcinoma

PharmaSources Customer Service